Current problems with thrombolytic agents in the management of acute myocardial infarction.
Pancholia
A K
AK
Department of Clinical & Preventive Cardiology, Arihant Hospital & RC, Indore, India. drpancholia@gmail.com
Sambi
R S
RS
Krishna
C K
CK
D005343:Fibrinolytic Agents / Q000627:therapeutic use; D049673:History, 20th Century; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use; D013300:Streptokinase / Q000627:therapeutic use; D015912:Thrombolytic Therapy / Q000266:history; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D011994:Recombinant Proteins; C081981:lanoteplase; C087896:reteplase; D013300:Streptokinase; D010959:Tissue Plasminogen Activator